Explore more publications!
Construction Press Releases
Got News to Share?

Construction Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Construction Press Releases.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on September 7, 2025

DECKO Launches DIY Deck, Garage and Wall Upgrades for American Homes
September 7, 2025

DECKO Launches DIY Deck, Garage and Wall Upgrades for American Homes

Indeterminate EIN Presswire
Sky Eye Network Success: Walter Everett Jr. Transforms His Life and Business Through Sky Eye Network
September 7, 2025

Sky Eye Network Success: Walter Everett Jr. Transforms His Life and Business Through Sky Eye Network

Indeterminate EIN Presswire
Sky Eye Network Success: Etta Marvin and Kay Brice Share Transformative Journey with BriMar Drone Command Center
September 7, 2025

Sky Eye Network Success: Etta Marvin and Kay Brice Share Transformative Journey with BriMar Drone Command Center

Indeterminate EIN Presswire
IAN LAZAR LIFESTYLE MAGAZINE COMMENCE MONTHLY FEATURES ON AN ARRAY OF HOME IMPROVEMENT MATTERS
September 7, 2025

IAN LAZAR LIFESTYLE MAGAZINE COMMENCE MONTHLY FEATURES ON AN ARRAY OF HOME IMPROVEMENT MATTERS

Indeterminate EIN Presswire
DataGlobal Hub’s GDAI 2025 Showcases the World’s Brightest Minds in Data and AI
September 7, 2025

DataGlobal Hub’s GDAI 2025 Showcases the World’s Brightest Minds in Data and AI

Indeterminate GlobeNewswire
Dianthus Therapeutics to Host Conference Call and Webcast to Discuss Results from Phase 2 MaGic Trial of Claseprubart (DNTH103) in Generalized Myasthenia Gravis
September 7, 2025

Dianthus Therapeutics to Host Conference Call and Webcast to Discuss Results from Phase 2 MaGic Trial of Claseprubart (DNTH103) in Generalized Myasthenia Gravis

Indeterminate GlobeNewswire
HexTrade.io Launches Game-Changing Futures Algorithmic Trading Platform
September 7, 2025

HexTrade.io Launches Game-Changing Futures Algorithmic Trading Platform

Indeterminate GlobeNewswire
New Porsche 911 Turbo S Celebrates World Premiere in Munich
September 7, 2025

New Porsche 911 Turbo S Celebrates World Premiere in Munich

Indeterminate GlobeNewswire
Junshi Biosciences Announces the Phase 3 Study of JS005 (IL-17A) for the Treatment of Moderate to Severe Plaque Psoriasis Met Primary Endpoints
September 7, 2025

Junshi Biosciences Announces the Phase 3 Study of JS005 (IL-17A) for the Treatment of Moderate to Severe Plaque Psoriasis Met Primary Endpoints

Indeterminate GlobeNewswire
HKC Group Enters Europe at IFA 2025 with Three Brands and Three World Premieres
September 7, 2025

HKC Group Enters Europe at IFA 2025 with Three Brands and Three World Premieres

Indeterminate GlobeNewswire
Un estudio sobre la genética del cáncer de pulmón lanza una plataforma de datos de código abierto para la comunidad investigadora
September 7, 2025

Un estudio sobre la genética del cáncer de pulmón lanza una plataforma de datos de código abierto para la comunidad investigadora

Indeterminate GlobeNewswire
Strongest Amanita Mushroom Gummies Announced by MoonWlkr for 2025 With Updated Formula and Expanded Testing
September 7, 2025

Strongest Amanita Mushroom Gummies Announced by MoonWlkr for 2025 With Updated Formula and Expanded Testing

Indeterminate GlobeNewswire
Welnax NeuroRelief Pro Officially Launches in 2025 as Consumer Demand for Nerve Relief Devices Expands
September 7, 2025

Welnax NeuroRelief Pro Officially Launches in 2025 as Consumer Demand for Nerve Relief Devices Expands

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions